Literature DB >> 7326869

Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis.

P L Haslam, O Cromwell, A Dewar, M Turner-Warwick.   

Abstract

In this study we report a significant increase in histamine in lung lavage fluids from a group of 33 patients with lone cryptogenic fibrosing alveolitis (lone CFA), and from a group of 13 patients having CFA in association with other connective tissue disorders, when compared with findings for 13 smoking patient controls without peripheral lung disease (P less than 0.001, P less than 0.05 respectively). The increases were independent of smoking or treatment. Significant correlations were obtained between the raised histamine levels in CFA and increased levels of albumin and increased counts of neutrophils and eosinophils in the lavage fluids, and with more pronounced fibrosis in CFA lung biopsies.. Thus histamine is associated with features of inflammation relating to progressive or more severe disease. No significant increase in histamine was observed in a group of 22 patients with sarcoidosis, although 21 had evidence of disease involving the lung parenchyma. There were, however, significantly higher levels in the patients with X-ray evidence of upper lobe contraction, suggestive of "fibrosis" (P less than 0.025). The levels also showed a correlation with increasing counts of lavage neutrophils (P less than 0.005), a feature also associated with X-ray evidence of contraction in this group. Mast cells were readily identified in biopsies from 12 CFA patients suggesting that these cells may provide one possible source of histamine in CFA lungs. These observations raise the question whether histamine, and/or possibly other substances derived from mast cells, plays any role in amplifying inflammation associated with pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326869      PMCID: PMC1537302     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Refinements in the automated fluorometric histamine analysis system.

Authors:  R P Siraganian
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

2.  Pathogenetic studies in idiopathic pulmonary fibrosis. Control of neutrophil migration by immune complexes.

Authors:  J Gadek; G Hunninghake; R Zimmerman; J Kelman; J Fulmer; R G Crystal
Journal:  Chest       Date:  1979-02       Impact factor: 9.410

3.  Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.

Authors:  J E Gadek; J A Kelman; G Fells; S E Weinberger; A L Horwitz; H Y Reynolds; J D Fulmer; R G Crystal
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

4.  Mediators of immediate type hypersensitivity in sputum from symptomatic young cigarette smokers.

Authors:  A G Leitch; A B Kay
Journal:  Chest       Date:  1979-02       Impact factor: 9.410

5.  Immunoglobulin levels in patients with sarcoidosis.

Authors:  D N Mitchell; J R Mikhail; M Turner-Warwick; I Sutherland
Journal:  Z Erkr Atmungsorgane       Date:  1977-08

6.  Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.

Authors:  P L Haslam; C W Turton; A Lukoszek; A J Salsbury; A Dewar; J V Collins; M Turner-Warwick
Journal:  Thorax       Date:  1980-05       Impact factor: 9.139

7.  Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders.

Authors:  O Kawanami; V J Ferrans; J D Fulmer; R G Crystal
Journal:  Lab Invest       Date:  1979-06       Impact factor: 5.662

  7 in total
  11 in total

1.  Bronchoalveolar mast cells in sarcoidosis: increased numbers and accentuation of mediator release.

Authors:  K C Flint; K B Leung; B N Hudspith; J Brostoff; F L Pearce; D Geraint-James; N M Johnson
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

2.  Elevated histamine content of lung lavage in human asbestosis.

Authors:  R Bégin; Y Desmarais; M Martel; R Boileau; Y Vézina; S Massé
Journal:  Lung       Date:  1986       Impact factor: 2.584

3.  Isolation and characterization of lung mast cells from rats with bleomycin-induced pulmonary fibrosis.

Authors:  M Tomioka; T Goto; T D Lee; J Bienenstock; A D Befus
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

4.  Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis.

Authors:  K A Boomars; S S Wagenaar; P G Mulder; H van Velzen-Blad; J M van den Bosch
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

5.  Mast cells and inhalation of asbestos in rats.

Authors:  M M Wagner; R E Edwards; C B Moncrieff; J C Wagner
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

Review 6.  Alveolitis: the key to the interstitial lung disorders.

Authors:  B A Keogh; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

7.  Mast cell and histamine content of human bronchoalveolar lavage fluid.

Authors:  R M Agius; R C Godfrey; S T Holgate
Journal:  Thorax       Date:  1985-10       Impact factor: 9.139

8.  Effect of histamine on proliferation of normal human adult lung fibroblasts.

Authors:  M Jordana; A D Befus; M T Newhouse; J Bienenstock; J Gauldie
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

9.  Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

Authors:  W B Davis; G A Fells; X H Sun; J E Gadek; A Venet; R G Crystal
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

Review 10.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.

Authors:  M N Sheppard; N K Harrison
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.